IBM’s Blockchain Patent Fire Sale Can’t Eclipse the Legal Storm Brewing Over Its Mainframe Meltdown
Published on 07/30/2026 at 13:01 | Redaktion boerse-global.de
IBM has offloaded its entire blockchain patent portfolio to Circle Internet Group, a move that underscores a broader strategic retreat from enterprise distributed-ledger technology even as the company scrambles to restore investor confidence after one of the worst single-day routs in its history.
Circle is acquiring more than 680 patent families and nearly 1,000 granted patents from IBM, covering everything from foundational blockchain protocols to banking, insurance, supply-chain verification and secure cloud infrastructure. The deal instantly makes Circle the largest holder of blockchain patents in the United States. Neither side disclosed financial terms, though the two companies said they would explore additional business opportunities together going forward.
The transaction drew sharply contrasting reactions. Crypto analyst Scott Melker noted that IBM had poured years of investment into enterprise blockchain, only to exit the space entirely, handing over its entire intellectual property position at what he described as a favorable price for Circle. In Melker’s view, the acquirer is chiefly looking to fortify itself against intensifying competition in the stablecoin arena. On the day of the announcement, Circle shares rose 2.8 percent in premarket trading, while IBM gained 1.6 percent.
That modest uptick for IBM came amid a fragile recovery from a devastating July selloff. The stock now trades at around €198.00, having climbed 9.04 percent over the past seven trading sessions. But that rally follows a historic crash triggered by a preliminary profit warning on July 14, when CEO Arvind Krishna disclosed that second-quarter results would fall well short of expectations.
Should investors sell immediately? Or is it worth buying IBM?
The damage is far from repaired. On a monthly basis, IBM shares remain 19.56 percent in the red, and year-to-date losses stand at 23.82 percent. The stock has managed to recover 13.05 percent from its 52-week low of €175.14, reached on July 23, but the technical picture remains precarious. The relative strength index sits at 42.1, signaling neutral-to-bearish territory despite the recent bounce.
The profit warning itself was devastating. IBM shares collapsed 25 percent in a single session, wiping out more than $68 billion in market capitalization. Krishna’s letter to shareholders revealed that total revenue had grown a meager 1 percent, while infrastructure revenue plunged 7 percent — both far weaker than the company had previously signaled. The CEO offered no excuses: “What developed was worse than anticipated, driven by a downturn in our Z performance and the associated software stack, particularly in transaction processing.” He pointed to delayed customer investment decisions and acknowledged that IBM had not adapted quickly enough.
That admission has now drawn the attention of multiple US law firms. Hagens Berman Sobol Shapiro launched an investigation on July 28 into possible securities law violations, focusing on whether IBM misled investors about its order pipeline before the warning. The firm is scrutinizing statements related to IBM Z, the mainframe line that has long been a cornerstone of the company’s enterprise business. Lead attorney Reed Kathrein framed the central question bluntly: Did IBM know during the second quarter that major contracts could not be completed on time, and if so, when exactly did that knowledge emerge?
Bleichmar Fonti & Auld has opened its own parallel investigation. With three separate announcements within days — on July 24, 27 and 29 — the legal pressure is mounting rather than easing. At the heart of each probe is the same allegation: that IBM may have misled the market about the health of its mainframe pipeline before the July 14 bombshell.
The official second-quarter results confirmed the grim picture. The software division, IBM’s strongest performer, generated $7.76 billion in revenue, up 5 percent. But infrastructure revenue fell 7 percent, and the Z mainframe business cratered 42 percent. For the full year, IBM still expects constant-currency revenue growth of 4 to 5 percent and a roughly $1 billion increase in free cash flow versus the prior year. The board is maintaining its dividend policy, with a quarterly payout of $1.69 per share payable to shareholders of record as of August 10, 2026 — extending an uninterrupted annual dividend streak that dates back to 1916.
IBM at a turning point? This analysis reveals what investors need to know now.
Away from the mainframe turmoil and the blockchain exit, IBM is quietly expanding its cybersecurity business. A new native integration brings threat intelligence data from Resecurity into the QRadar platform, allowing customers to monitor and analyze security events from multiple sources in a single console. The move aligns with a broader industry trend as companies seek automated defense solutions against a rising tide of AI-powered attacks. IBM is positioning QRadar as a central hub for AI-ready security data.
The blockchain patent sale represents a clean break from a field where IBM once invested heavily. The company’s focus is now squarely on software, hybrid cloud and artificial intelligence — though the weak mainframe business continues to cast a long shadow. Whether that strategic pivot gains traction will become clearer in the coming quarters, as software and consulting revenue trends provide the real test.
For now, IBM’s recovery is a two-front battle. Operationally, the company needs to stabilize its mainframe business and demonstrate that the July disaster was an anomaly, not a structural shift. Legally, it must navigate investigations that could produce formal lawsuits or settlements, each of which would further influence investor sentiment. The stock’s current price of around €198.26 — down 32.30 percent from its year-high of €292.85 on June 1 and 14.93 percent below its 200-day moving average — suggests the market is still pricing in considerable uncertainty. Analyst targets compiled by Zacks Research show a wide dispersion, reflecting deep disagreement about how to weigh the profit-warning shock against IBM’s still-substantial software and services franchise.
Ad
IBM Stock: New Analysis - 30 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
